SIRT6-PAI-1 axis is a promising therapeutic target in aging-related bone metabolic disruption

Bibliographic Details
Title: SIRT6-PAI-1 axis is a promising therapeutic target in aging-related bone metabolic disruption
Authors: Alkebaier Aobulikasimu, Tao Liu, Jinying Piao, Shingo Sato, Hiroki Ochi, Atsushi Okawa, Kunikazu Tsuji, Yoshinori Asou
Source: Scientific Reports, Vol 13, Iss 1, Pp 1-16 (2023)
Publisher Information: Nature Portfolio, 2023.
Publication Year: 2023
Collection: LCC:Medicine
LCC:Science
Subject Terms: Medicine, Science
More Details: Abstract The mechanistic regulation of bone mass in aged animals is poorly understood. In this study, we examined the role of SIRT6, a longevity-associated factor, in osteocytes, using mice lacking Sirt6 in Dmp-1-expressing cells (cKO mice) and the MLO-Y4 osteocyte-like cell line. cKO mice exhibited increased osteocytic expression of Sost, Fgf23 and senescence inducing gene Pai-1 and the senescence markers p16 and Il-6, decreased serum phosphate levels, and low-turnover osteopenia. The cKO phenotype was reversed in mice that were a cross of PAI-1-null mice with cKO mice. Furthermore, senescence induction in MLO-Y4 cells increased the Fgf23 and Sost mRNA expression. Sirt6 knockout and senescence induction increased HIF-1α binding to the Fgf23 enhancer sequence. Bone mass and serum phosphate levels were higher in PAI-1-null aged mice than in wild-type mice. Therefore, SIRT6 agonists or PAI-1 inhibitors may be promising therapeutic options for aging-related bone metabolism disruptions.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2045-2322
Relation: https://doaj.org/toc/2045-2322
DOI: 10.1038/s41598-023-33297-7
Access URL: https://doaj.org/article/d194b5107db345eb9a57e9816ffdca71
Accession Number: edsdoj.194b5107db345eb9a57e9816ffdca71
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:20452322
DOI:10.1038/s41598-023-33297-7
Published in:Scientific Reports
Language:English